Literature DB >> 1530808

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

I S Udvarhelyi1, G A Colditz, A Rai, A M Epstein.   

Abstract

OBJECTIVE: To determine whether published cost-effectiveness and cost-benefit analyses have adhered to basic analytic principles.
DESIGN: Structured methodologic review of published articles. STUDY SAMPLE: Seventy-seven articles published either from 1978 to 1980 or from 1985 to 1987 in general medical, general surgical, and medical subspecialty journals. MAIN OUTCOME MEASUREMENTS: Articles were reviewed to assess the use and reporting of six fundamental principles of analysis. These principles were derived by reviewing widely cited textbooks and articles describing the methods for performing economic analyses and by selecting the methods universally recommended. MAIN
RESULTS: Overall performance was only fair. Three articles adhered to all six principles, and the median number of principles to which articles adhered was three. Among the problems noted were failure to make underlying assumptions explicit and, therefore, verifiable, and failure to test assumptions with sensitivity analyses. No improvement in performance was observed between 1978 and 1987. Articles in general medical journals, however, were more likely to use analytic methods appropriately than articles in the general surgical or medical subspecialty literature.
CONCLUSIONS: Greater attention should be devoted to ensuring the appropriate use of analytic methods for economic analyses, and readers should make note of the methods used when interpreting the results of economic analyses.

Mesh:

Year:  1992        PMID: 1530808     DOI: 10.7326/0003-4819-116-3-238

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  73 in total

Review 1.  Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making.

Authors:  R Baltussen; R Leidl; A Ament
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 2.  Methodological hurdles in conducting pharmacoeconomic analyses.

Authors:  J D Rizzo; N R Powe
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 3.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

4.  Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective.

Authors:  S C Wood; V H Nguyen; C Schmidt
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

5.  Savings from four transport safety efforts in native America.

Authors:  E Zaloshnja; T R Miller; B Lawrence; K R Hicks; M Keiffer; N Bill
Journal:  Annu Proc Assoc Adv Automot Med       Date:  2000

6.  Quality of economic evaluations in health care.

Authors:  Tom Jefferson; Vittorio Demicheli
Journal:  BMJ       Date:  2002-02-09

Review 7.  Cost effectiveness of continuing professional development in health care: a critical review of the evidence.

Authors:  C A Brown; C R Belfield; S J Field
Journal:  BMJ       Date:  2002-03-16

8.  Economic analysis of randomized, controlled trials.

Authors:  G H Lyman
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 9.  Pharmacoeconomic fellowships: the need for outcome measures.

Authors:  V Maio; T K Girts; J H Lofland; D B Nash
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 10.  The role of government and private insurers in guiding and implementing pharmacoeconomic analyses.

Authors:  D A Freund; B R Luce
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.